STEPHENS KRISTIN (Chief Development Officer) exercised options at SYROS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/2/2023ACC: 0001209191-23-054168
Officer· Chief Development Officer
Since Jun 2021
-5.68K
Net shares
Net seller
$12.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
17K acquired · 22.68K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+17K
Price / share
—
Trade value
—
% of position
380.7%
10/31/2023
4.46K→21.46K
Common Stock
Direct
Shares
−5.68K
Price / share
$2.22
Trade value
$12.60K
% of position
26.4%
11/1/2023
21.46K→15.79K
Total
Net shares
+11.32K
Net value
-$12.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/31/2023 | M · Option Exercise | +17K | — | — | 380.7% | 4.46K | 21.46K |
| Common Stock Direct | 11/1/2023 | F · Tax Withholding | −5.68K | $2.22 | $12.60K | 26.4% | 21.46K | 15.79K |
| Total | +11.32K | -$12.60K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
17K shares
Shares
−17K
Strike price
Held after
17K
Exercisable
—
10/31/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock17K shares | 10/31/2023 | M · Option Exercise | −17K | — | 17K |